NIKKEI 225
33,434.55 +26.16 (+0.08%) HANG SENG
17,038.70 -315.44 (-1.82%) CRUDE OIL
76.55 +0.14 (+0.18%) GOLD FUTURES
2,044.80 +4.80 (+0.24%) DOW
35,416.98 +83.51 (+0.24%) Bitcoin GBP
29,841.81 +640.45 (+2.19%)
Hims & Hers Health, Inc. (HIMS)
After hours:
| Previous close | 8.27 |
| Open | 8.23 |
| Bid | 8.30 x 3000 |
| Ask | 8.50 x 3100 |
| Day's range | 8.13 - 8.48 |
| 52-week range | 5.65 - 12.34 |
| Volume | |
| Avg. volume | 2,439,451 |
| Market cap | 1.781B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.17 |
| Earnings date | 26 Feb 2024 - 01 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.75 |
Business WireHims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company," NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years. Hims & Hers intends to use the program to repurchase shares on a discretionary basis from time to time, subject to general business and market conditions and other investment opportunit
- Business Wire
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today reported financial results for the third quarter ended September 30, 2023.
Business WireHims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services
SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS), the leading health and wellness platform, today introduced MedMatch, a technology designed to transform healthcare by giving providers a more intelligent and informed way to deliver personalized care to patients with more effective and precise treatments and medications.
